U.S., Jan. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07329907) titled 'Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic' on Dec. 29, 2025.
Brief Summary: Objective: To compare the efficacy, safety, and recurrence rates of topical salicylic acid/lactic acid (SA/LA) monotherapy (Group A), intralesional Candida antigen (CA) monotherapy (Group B), and their combination (Group C) for the treatment of warts.
Study Start Date: Dec. 01, 2023
Study Type: INTERVENTIONAL
Condition:
Warts
Human Papilloma Virus (HPV)
Intervention:
DRUG: Salicylic Acid/Lactic Acid Topical Solution
Patients receive topical application of Salicylic Acid 40% and Lactic Acid 16% once daily for up to 6 weeks....